Avidity Biosciences, Inc (RNAM) — Net Asset Momentum
Avidity Biosciences, Inc (RNAM) recorded a net asset momentum of 18.5% as of December 2025, with net assets of $1.69 Billion USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check Avidity Biosciences, Inc (RNAM) tangible equity ratio to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Avidity Biosciences, Inc Net Asset Momentum (2018–2025)
This chart tracks Avidity Biosciences, Inc's year-over-year net asset growth across 8 annual reporting periods from 2018 to 2025. The most recent momentum reading is +18.5%, with net assets of $1.69 Billion USD as of December 2025. Read total liabilities of Avidity Biosciences, Inc for a breakdown of total debt and financial obligations.
Annual Net Asset History for Avidity Biosciences, Inc (2018–2025)
The table below shows the complete annual net asset history for Avidity Biosciences, Inc from 2018 to 2025, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Avidity Biosciences, Inc (RNAM) total market value.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $1.69 Billion | $1.96 Billion | $269.45 Million | ▲ +18.5% |
| 2024 | $1.42 Billion | $1.56 Billion | $138.94 Million | ▲ +184.6% |
| 2023 | $500.76 Million | $628.55 Million | $127.79 Million | ▼ -13.4% |
| 2022 | $578.08 Million | $638.80 Million | $60.73 Million | ▲ +51.6% |
| 2021 | $381.43 Million | $427.58 Million | $46.15 Million | ▲ +24.6% |
| 2020 | $306.22 Million | $333.90 Million | $27.68 Million | ▲ +568.5% |
| 2019 | $-65.36 Million | $96.91 Million | $162.26 Million | ▼ -58.9% |
| 2018 | $-41.13 Million | $3.98 Million | $45.11 Million | — |